Skip to main content
. 2022 Jun 8;12:890337. doi: 10.3389/fonc.2022.890337

Table 1.

Concentrations achieved in urine and serum after a specific dose application for individual quinolones.

Quinolone Dose [mg] Concentrations achieved in the urine [µg/ml] Concentrations achieved in serum [µg/ml] Reference
Nalidixic acid 1,000 100 27.3 (24)
Pipemidic acid 100 400 1.23 (25)
400 –––– 3.64 (26)
500 900 3.38 (25)
Ciprofloxacin 250 205–261 1.35–1.42 (27)
500 255–518 2.60–2.89
750 243–846 3.41–4.21
Ofloxacin 400 119 5.5 (28)
Fleroxacin 200 >200 –––– (29)
100 68 2.9 (30)
400 224 4.2
800 490 9.4
1,200 715 11.9
Norfloxacin 200 200 0.75 (31)
400 478 1.58
800 697 2.41
1,200 992 3.15
1,600 1045 3.87
Enoxacin 200 119–685 1.83 (32)
800 379–1287 6.58
Lomefloxacin 100 104–713* 1.11 (33)
200 2.46
400 3.02
600 4.79
800 7.46
Pefloxacin 400 –––– 3.66–9.06 (34)
800 219 –––– (35)
Levofloxacin 500 406 5.61 (36)
Grepafloxacin 400 15.4 1.5 (37)
Gatifloxacin 400 111–649 1.53–2.46 (38)
Sparfloxacin 400 5.4–19.9 1.2–1.9 (39)
Trovafloxacin 200 –––– 3.2 (40)
300 7.3 3.0
Moxifloxacin 400 127 6.80 (41)
Gemifloxacin 160 –––– 0.92 (42)
320 55 2.01
480 –––– 2.0
640 –––– 3.03
Finafloxacin 25 –––– 0.24 (43)
50 –––– 0.44
100 0.1–101 1.32
200 0.5–166 1.90
400 1.4–328 5.06
800 0.7–257 11.1

*These values are range of concentrations achieved in urine for all tested doses of lomefloxacin.